New Survey from B + L and GRF Reveals Emotional and Social Impact of Hyperemia on Glaucoma Patients
Tuesday, January 4 2022 | 11 h 36 min | News, Press Release
Bausch + Lomb and Glaucoma Research Foundation (GRF), a national non-profit organization with the vision of curing glaucoma, today released, during...
Read More Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03
Wednesday, October 6 2021 | 11 h 29 min | News, Press Release
Bausch + Lomb and Novaliq announced statistically significant topline data from the second Phase 3 (MOJAVE) trial evaluating the investigational...
Read More
Bausch + Lomb and Clearside Biomedical Announce U.S. FDA Filing Acceptance for XIPERE
Friday, June 4 2021 | 15 h 48 min | News, Press Release
Bausch + Lomb, along with Clearside Biomedical, a biopharmaceutical company dedicated to developing and delivering treatments that restore and...
Read More Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry Eye, News, Press Release
Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...
Read More Bausch + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled
Monday, November 16 2020 | 10 h 26 min | News, Press Release
Bausch + Lomb announced that its exclusive ONE by ONE Recycling program has recycled nearly 27 million used contact lenses, top foils and...
Read More
